Compare GHC & BCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GHC | BCPC |
|---|---|---|
| Founded | 1877 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Major Chemicals |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 5.8B |
| IPO Year | 1994 | 1995 |
| Metric | GHC | BCPC |
|---|---|---|
| Price | $1,045.02 | $182.96 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $176.00 |
| AVG Volume (30 Days) | 14.2K | ★ 143.4K |
| Earning Date | 05-28-2026 | 05-25-2026 |
| Dividend Yield | ★ 0.71% | 0.53% |
| EPS Growth | N/A | ★ 20.87 |
| EPS | ★ 66.47 | 4.75 |
| Revenue | ★ $2,932,099,000.00 | $799,023,000.00 |
| Revenue This Year | $10.54 | $7.99 |
| Revenue Next Year | $4.02 | $2.77 |
| P/E Ratio | ★ $15.76 | $38.35 |
| Revenue Growth | N/A | ★ 13.56 |
| 52 Week Low | $875.60 | $139.17 |
| 52 Week High | $1,224.76 | $183.01 |
| Indicator | GHC | BCPC |
|---|---|---|
| Relative Strength Index (RSI) | 36.03 | 67.27 |
| Support Level | $913.37 | $149.11 |
| Resistance Level | $1,115.27 | $183.01 |
| Average True Range (ATR) | 36.31 | 5.35 |
| MACD | -5.77 | 0.12 |
| Stochastic Oscillator | 20.05 | 94.02 |
Graham Holdings Co. is a diversified education and media company made up of subsidiaries. Firm operations include educational services; television broadcasting; online, print, and local news; home health and hospice care; and manufacturing. The Company segments into the following seven reportable segments: Kaplan International, Higher Education, Supplemental Education, Television Broadcasting, Manufacturing, Healthcare, and Automotive. The majority of revenue comes from the Kaplan International segment, which includes higher education, test preparation, language instruction, and professional training. A large portion of company revenue also comes from the television broadcasting segment through advertising.
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.